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it looked like an absolutely normal aorta upstream and an abso-
lutely normal downstream but I forget what it was, 2 or 3 years
later, we have a problem downstream with aorta enlarging, and we
know that the pathology of the aorta is always much greater than
the CT scan, magnetic resonance imaging, or the dye study shows.
Most of the aneurysms I operate on have a calcified arch that I am
dealing with or down at the diaphragm an aneurysm that is running
through the diaphragm; there is clot, there is a double-barrel lumen
fusiform aneurysm related to dissection. So I don’t believe that this
technology will ever do away with surgical repair of descending
thoracic aneurysms, but with increased improvement in selection
of patients and with increased improvement in technology of the
stents, I think there is a bright future for a small window of patients
in whom we will be able to do this.
I really have 1 question. We all have met the 75-year-old
grandma in the middle of the night who is hypertensive with an
acute type III dissection and we usually treat these medically and
3 days later we are called because now she has a big pleural
effusion and she is leaking. We all know that our surgical results
are dismal in this setting. Have you had any experience, Dr
Demers, or plans for any experience in dealing with this in a
prophylactic situation? It seems to me if there is a great asset to
this technology it would be in this patient in which we could
prophylactically put a stent in the location of the tear, which is
somewhere around the takeoff of the left subclavian, and protect
these people from ending up on the operating table 2 or 3 days later.
Dr Demers. Thank you, Dr Floten, for your nice comments.
Very few patients with acute or chronic type B dissection were
included in this series, so I cannot directly answer your question
with our data. We certainly don’t have experience at Stanford with
stent-graft treatment of uncomplicated acute type B dissections.
We try to treat all uncomplicated acute type B dissections medi-
cally and will consider surgical or endovascular treatment for
complicated cases. However, I am aware of a multicenter Euro-
pean trial comparing endovascular stent-graft treatment versus
medical therapy conducted right now in Europe by Dr Nienaber
from Germany. They also have another trial comparing surgical
therapy versus stent-graft repair in patients with complicated dis-
sections, so hopefully these trials will answer some of these
questions.
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